Connect with us

Hi, what are you looking for?


Exclusive: ChemChina seeks to raise $10 billion from Syngenta IPO – sources

Stock Markets31 minutes ago (Jun 30, 2021 02:40AM ET)

(C) Reuters. FILE PHOTO: A Syngenta logo is seen at its China headquarters in Beijing, China July 16, 2018. REUTERS/Jason Lee/File Photo

By John Revill and Julie Zhu

ZURICH/HONG KONG (Reuters) – ChemChina, the owner of Syngenta Group, is aiming to raise around 65 billion yuan ($10 billion) from an IPO for the Swiss agrichemical giant on Shanghai’s STAR Market, sources familiar with matter told Reuters.

Syngenta will likely post the prospectus for its upcoming initial public offering later on Wednesday, sources have told Reuters, clearing the way for its flotation by the end of 2021.

The IPO would value Syngenta at around $60 billion including debt, or $50 billion without, said the sources who were not authorised to speak to media and declined to comment.

Syngenta spokesman Saswato Das declined to comment.

ChemChina, which bought Syngenta for $43 billion in 2017, last year merged the Swiss firm with Israel’s ADAMA and the fertiliser and seed business of Sinochem.

A long planned merger of ChemChina and Sinochem was approved by China’s state assets regulator in March.

Exclusive: ChemChina seeks to raise $10 billion from Syngenta IPO – sources

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Stock Markets25 minutes ago (Jul 16, 2021 05:46PM ET) (C) Reuters. FILE PHOTO: Johnson & Johnson’s Neutrogena Cool Dry Sport sunscreen, which is part...


Builders, creators and developers, this one’s for you! TechCrunch has always been about discovering fresh solutions and shining the light on exciting, new products...

Disclaimer: it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved